Evaluation of Refractive Errors and Ocular Biometric Outcomes after Intravitreal Bevacizumab for Retinopathy of Prematurity


Gunay M. , ŞEKEROĞLU M. A. , Bardak H., ÇELİK G., ESENÜLKÜ C. M. , HEKİMOĞLU E., ...More

STRABISMUS, vol.24, no.2, pp.84-88, 2016 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.3109/09273972.2016.1159232
  • Title of Journal : STRABISMUS
  • Page Numbers: pp.84-88
  • Keywords: Biometry, intravitreal injection, refraction, retinopathy of prematurity, THRESHOLD RETINOPATHY, PRETHRESHOLD RETINOPATHY, LASER PHOTOCOAGULATION, DIODE-LASER, VISUAL FUNCTION, CRYOTHERAPY, INFANTS, CHILDREN, EYES, THERAPY

Abstract

Purpose: To assess ocular biometric outcomes following intravitreal bevacizumab (IVB) monotherapy for retinopathy of prematurity (ROP) and compare these results with those of laser photocoagulated infants and with the ones with spontaneously regressed ROP.